Showing results (121-130 of 388) with videos related to
Sort By:
Pageof 39
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 23, 2026
Association between shoulder joint radiation dose and arm morbidity in the randomized breast cancer trial SENOMACSara Alkner, Matilda Appelgren, Robert Szulkin, et al.Molecular Oncology|May 29, 2020
What will radiation oncology look like in 2050? A look at a changing professional landscape in Europe and beyondMichael Baumann, Nadja Ebert, Ina Kurth, et al.Journal of Experimental Therapeutics & Oncology|October 22, 2003
Low-dose total body irradiation augments the therapeutic effect of interleukin-2 in a mouse model for metastatic malignant melanomaAkmal Safwat, Ninna Aggerholm, Ivan Roitt, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 22, 2007
Hypoxia induced expression of endogenous markers in vitro is highly influenced by pHBrita Singers Sørensen, Jan Alsner, Jens Overgaard, et al.European Journal of Cancer (Oxford, England : 1990)|June 5, 2004
Tumour burden and interleukin-2 dose affect the interaction between low-dose total body irradiation and interleukin 2Akmal Safwat, Ninna Aggerholm, Ivan Roitt, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 9, 2011
Dependence of cell survival on instantaneous dose rate of a linear acceleratorBrita Singers Sørensen, Anne Vestergaard, Jens Overgaard, et al.Acta Oncologica (Stockholm, Sweden)|July 11, 2003
Validity and representativity in the Danish Breast Cancer Cooperative Group--a study on protocol allocation and data validity from one county to a multi-centre databaseAnni R Jensen, Hans H Storm, Susanne Møller, et al.Acta Oncologica (Stockholm, Sweden)|November 30, 2012
Feasibility and efficacy of progressive resistance training and dietary supplements in radiotherapy treated head and neck cancer patients--the DAHANCA 25A studySimon Lønbro, Ulrik Dalgas, Hanne Primdahl, et al.The Lancet. Oncology|August 9, 2024
Completion axillary lymph node dissection for the identification of pN2-3 status as an indication for adjuvant CDK4/6 inhibitor treatment: a post-hoc analysis of the randomised, phase 3 SENOMAC trialJana de Boniface, Matilda Appelgren, Robert Szulkin, et al.International Journal of Radiation Oncology, Biology, Physics|January 31, 2004
The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neckJesper Grau Eriksen, Torben Steiniche, Jon Askaa, et al.Pageof 39